LoQus23 are discovering oral small molecule therapies targeting aberrant DNA mismatch repair to effectively treat Huntington’s and other triplet repeat diseases.
LoQus23 Therapeutics Ltd Address
Building 522, Babraham Research Campus Cambridge, Cambridgeshire